Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
Mark van Barele, Bernadette A. M. Heemskerk‐Gerritsen, Yvonne V. Louwers, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2506-2506
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway
Nathalie C. Støer, Siri Vangen, Deependra Singh, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 1, pp. 126-137
Open Access | Times Cited: 12
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis
Francesca Poggio, Lucia Del Mastro, Marco Bruzzone, et al.
Breast Cancer Research and Treatment (2021) Vol. 191, Iss. 2, pp. 269-275
Closed Access | Times Cited: 49
Novel Combination Therapy for Triple-Negative Breast Cancer based on an Intelligent Hollow Carbon Sphere
Yue Yin, Yaping Yan, Biao Fan, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 19
Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism
Channa N. Jayasena, Kerri Devine, Katie E. Barber, et al.
Clinical Endocrinology (2024) Vol. 101, Iss. 5, pp. 409-442
Open Access | Times Cited: 7
Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions
Annice Mukherjee, Susan R. Davis
Clinical Endocrinology (2025)
Open Access
Interplay between Estrogen, Kynurenine, and AHR Pathways: An immunosuppressive axis with therapeutic potential for breast cancer treatment
Jorge H. Limón-Pacheco, Guillermo Elizondo
Biochemical Pharmacology (2023) Vol. 217, pp. 115804-115804
Closed Access | Times Cited: 12
Updates on Triple-Negative Breast Cancer in Type 2 Diabetes Mellitus Patients: From Risk Factors to Diagnosis, Biomarkers and Therapy
Sabine Matou‐Nasri, M Sarawatense Aldawood, Fatimah Alanazi, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2390-2390
Open Access | Times Cited: 11
Investigating the Correlation Between β-hCG and CA125 in Patients with Endometrial Cancer: A 10-Year Retrospective Analysis
Mahdiss Mohamadianamiri, Ainaz Sourati, Sahand Karimzadhagh, et al.
Indian Journal of Gynecologic Oncology (2025) Vol. 23, Iss. 1
Closed Access
Incidence, patient characteristics and treatment patterns of early-stage triple-negative breast cancer (TNBC) in Bulgaria: A retrospective analysis based on real-world data
Jeliazko Arabadjiev, Assia Konsoulova, Rositsa Krasteva, et al.
Pharmacia (2025) Vol. 72, pp. 1-6
Open Access
Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update
Lucia Merlino, Giulia D’Ovidio, Viviana Matys, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 550-550
Open Access | Times Cited: 9
Comprehensive understanding of the role of GPER in estrogen receptor-alpha negative breast cancer
Manal A. Abbas, Aya Y. Al-Kabariti, Chris W. Sutton
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 241, pp. 106523-106523
Closed Access | Times Cited: 2
Menopausal hormone therapy and incidence, mortality, and survival of breast cancer subtypes: a prospective cohort study
Marit Busund, Giske Ursin, Eiliv Lund, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2
CmPn signaling networks in the tumorigenesis of breast cancer
Mellisa Renteria, Ofek Belkin, David Jang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11
Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy
Sarah Collet, Noor C. Gieles, Chantal M Wiepjes, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 2, pp. 331-338
Open Access | Times Cited: 10
Gynecological management of the breast cancer survivor
Mary Kathryn Abel, Tamandra Morgan, Alisha Othieno, et al.
Best Practice & Research Clinical Obstetrics & Gynaecology (2022) Vol. 82, pp. 69-80
Closed Access | Times Cited: 8
Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer
Xue Hu, Qiang Zhang, Wanying Xing, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Circulating tumor DNA (ctDNA) application in investigation of cancer: Bench to bedside
Hashem O. Alsaab, Mohammad S. Alzahrani, Ammar Abdulraheem Bahauddin, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 758, pp. 110066-110066
Closed Access | Times Cited: 1
Estrogen Regulated Genes Compel Apoptosis in Breast Cancer Cells, Whilst Stimulate Antitumor Activity in Peritumoral Immune Cells in a Janus-Faced Manner
Zsuzsanna Suba
(2024)
Open Access | Times Cited: 1
Estrogen Regulated Genes Compel Apoptosis in Breast Cancer Cells, Whilst Stimulate Antitumor Activity in Peritumoral Immune Cells in a Janus-Faced Manner
Zsuzsanna Suba
Current Oncology (2024) Vol. 31, Iss. 9, pp. 4885-4907
Open Access | Times Cited: 1
Menopause hormone treatment after cancer
Anne Gompel
Climacteric (2023) Vol. 26, Iss. 3, pp. 240-247
Open Access | Times Cited: 3
Targeted cytotoxicity against MDA-MB- 231 triple-negative breast cancer cells with Borassus flabellifer haustorium-derived silver nanoparticles: An integrated in silico and experimental approach
Noorul Samsoon Maharifa Haja Mohaideen, Karunya Jenin Ravindranath, S. Hemalatha
Biocatalysis and Agricultural Biotechnology (2023) Vol. 54, pp. 102952-102952
Closed Access | Times Cited: 3
Molecular Subtypes of Breast Cancer and CDk Dysregulation
Manzoor Ahmad Mir, Ifshana Mohi Ud Din
(2023), pp. 133-148
Closed Access | Times Cited: 2
NOTCH, SUMOylation and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Score Between Expressing or not Estrogen Receptor Breast Cancer in Three Public EWAS Datasets
Luigi Corsaro, Vincenzo Sandro Gambino
(2023)
Open Access | Times Cited: 2
Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets
Luigi Corsaro, Davide Gentilini, Luciano Calzari, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4109-4109
Open Access | Times Cited: 2
Borassus flabellifer: A Multipurpose Tree with Potential Applications
Noorul Samsoon Maharifa Haja Mohaideen, S. Hemalatha
Current Pharmacology Reports (2024)
Closed Access
Page 1 - Next Page

Scroll to top